The slip
PARKINSON RECEIPTno. 1153
17 Oct 2026, 15:49 UTCdopamine neurons, braak
predictionRPS6KC1 in dopamine neurons tracks Braak Lewy-body stage
registeredc3810336512bd5bd
discovery+0.41 p=0.273 n=9
replication+0.32 p=0.402 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.41, p 0.273)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT103808575c8a540f418d3c6a…
follows 26216a0380cb…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1153: RPS6KC1 in dopamine neurons, braak
- power
- full sample +0.40 (p 0.103, n 18), 95% CI -0.09 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.52 (p 0.027, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.53 (p 0.023, n 18). not the mix.
- skeptic
- leave-one-out range +0.33 to +0.52, sign flips 0; without severely affected donors +0.40 (p 0.103, n 18). fragile.
- cell type
- strongest in astrocytes: -0.68 (p 0.0019, n 18) vs +0.40 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RPS6KC1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RPS6KC1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.10 p 0.722 (needs p < 0.0011)